- A peptide-based vaccine candidate, called CoVac-1, is shown to induce immunity against SARS-CoV-2 in a phase I clinical trial reported in Nature. The vaccine candidate induces T cell immunity and could be helpful for people with immunodeficiencies. https://www.nature.com/articles/s41586-021-04232-5?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature 3 comments science
- A peptide-based vaccine candidate, called CoVac-1, is shown to induce immunity against SARS-CoV-2 in a phase I clinical trial reported in Nature. The vaccine candidate induces T cell immunity and could be helpful for people with immunodeficiencies. https://www.nature.com/articles/s41586-021-04232-5?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NGMT_USG_JC01_GL_Nature 6 comments science
Linking pages
- Covid-19 Vaccine Tracker: Latest Updates - The New York Times https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html 0 comments
- How scientists are looking at T cells to develop stronger vaccines – The Hill https://thehill.com/changing-america/well-being/prevention-cures/3484772-how-scientists-are-looking-at-t-cells-to-develop-stronger-vaccines/ 0 comments
Linked pages
- Creative Commons — Attribution 4.0 International — CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ 95 comments
- Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations - nCoV-2019 Genomic Epidemiology - Virological https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 4 comments
Related searches:
Search whole site: site:nature.com
Search title: A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity | Nature
See how to search.